Lv3
297 积分 2022-07-19 加入
A Type 2 Diabetes–Associated Functional Regulatory Variant in a Pancreatic Islet Enhancer at the ADCY5 Locus
1天前
已完结
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
11天前
已完结
GLP-1 agonists: 82 deaths linked to adverse reactions, UK data show
21天前
已完结
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
22天前
已完结
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
22天前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
22天前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
22天前
已完结
Role of semaglutide in the treatment of nonalcoholic fatty liver disease or non-alcoholic steatohepatitis: A systematic review and meta-analysis
22天前
已完结
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
22天前
已完结
A systematic review of the effect of semaglutide on lean mass: insights from clinical trials
23天前
已完结
皖公网安备34019202002308
